- •Table of Contents
- •Copyright
- •Contributors
- •How to Use this Study Guide
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •4: Outcomes Research
- •Questions
- •Answers
- •5: Core Principles of Perioperative Care
- •Questions
- •Answers
- •Questions
- •Answers
- •7: Principles of Urologic Endoscopy
- •Questions
- •Answers
- •8: Percutaneous Approaches to the Upper Urinary Tract Collecting System
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •12: Infections of the Urinary Tract
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •15: Sexually Transmitted Diseases
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •20: Principles of Tissue Engineering
- •Questions
- •Answers
- •Questions
- •Answers
- •22: Male Reproductive Physiology
- •Questions
- •Answers
- •Questions
- •Answers
- •24: Male Infertility
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •28: Priapism
- •Questions
- •Answers
- •Questions
- •Answers
- •30: Surgery for Erectile Dysfunction
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •34: Neoplasms of the Testis
- •Questions
- •Answers
- •35: Surgery of Testicular Tumors
- •Questions
- •Answers
- •36: Laparoscopic and Robotic-Assisted Retroperitoneal Lymphadenectomy for Testicular Tumors
- •Questions
- •Answers
- •37: Tumors of the Penis
- •Questions
- •Answers
- •38: Tumors of the Urethra
- •Questions
- •Answers
- •39: Inguinal Node Dissection
- •Questions
- •Answers
- •40: Surgery of the Penis and Urethra
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •47: Renal Transplantation
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •50: Upper Urinary Tract Trauma
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •53: Strategies for Nonmedical Management of Upper Urinary Tract Calculi
- •Questions
- •Answers
- •54: Surgical Management for Upper Urinary Tract Calculi
- •Questions
- •Answers
- •55: Lower Urinary Tract Calculi
- •Questions
- •Answers
- •56: Benign Renal Tumors
- •Questions
- •Answers
- •57: Malignant Renal Tumors
- •Questions
- •Answers
- •Questions
- •Answers
- •59: Retroperitoneal Tumors
- •Questions
- •Answers
- •60: Open Surgery of the Kidney
- •Questions
- •Answers
- •Questions
- •Answers
- •62: Nonsurgical Focal Therapy for Renal Tumors
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •66: Surgery of the Adrenal Glands
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •71: Evaluation and Management of Women with Urinary Incontinence and Pelvic Prolapse
- •Questions
- •Answers
- •72: Evaluation and Management of Men with Urinary Incontinence
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •76: Overactive Bladder
- •Questions
- •Answers
- •77: Underactive Detrusor
- •Questions
- •Answers
- •78: Nocturia
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •82: Retropubic Suspension Surgery for Incontinence in Women
- •Questions
- •Answers
- •83: Vaginal and Abdominal Reconstructive Surgery for Pelvic Organ Prolapse
- •Questions
- •Answers
- •Questions
- •Answers
- •85: Complications Related to the Use of Mesh and Their Repair
- •Questions
- •Answers
- •86: Injection Therapy for Urinary Incontinence
- •Questions
- •Answers
- •87: Additional Therapies for Storage and Emptying Failure
- •Questions
- •Answers
- •88: Aging and Geriatric Urology
- •Questions
- •Answers
- •89: Urinary Tract Fistulae
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •92: Tumors of the Bladder
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •95: Transurethral and Open Surgery for Bladder Cancer
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •99: Orthotopic Urinary Diversion
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Answers
- •Questions
- •Answers
- •108: Prostate Cancer Tumor Markers
- •Questions
- •Answers
- •Questions
- •110: Pathology of Prostatic Neoplasia
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •114: Open Radical Prostatectomy
- •Questions
- •Answers
- •Questions
- •Answers
- •116: Radiation Therapy for Prostate Cancer
- •Questions
- •Answers
- •117: Focal Therapy for Prostate Cancer
- •Questions
- •Answers
- •Questions
- •Answers
- •119: Management of Biomedical Recurrence Following Definitive Therapy for Prostate Cancer
- •Questions
- •Answers
- •120: Hormone Therapy for Prostate Cancer
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •124: Perinatal Urology
- •Questions
- •Answers
- •Questions
- •Answers
- •126: Pediatric Urogenital Imaging
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •133: Surgery of the Ureter in Children
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •137: Vesicoureteral Reflux
- •Questions
- •Answers
- •138: Bladder Anomalies in Children
- •Questions
- •Answers
- •139: Exstrophy-Epispadias Complex
- •Questions
- •Answers
- •140: Prune-Belly Syndrome
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •144: Management of Defecation Disorders
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •147: Hypospadias
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
- •152: Adolescent and Transitional Urology
- •Questions
- •Answers
- •Questions
- •Answers
- •154: Pediatric Genitourinary Trauma
- •Answers
- •Questions
- •Answers
- •Questions
- •Answers
85
Complications Related to the Use of Mesh and Their Repair
Shlomo Raz; Lisa Rogo-Gupta
Questions
1.Which of the following statements is TRUE?
a.Urinary obstruction always presents with elevated postvoid residuals.
b.Mesh exposure is necessary to diagnose a patient with mesh complications.
c.Vaginal estrogen sometimes resolves mesh exposure.
d.If a patient does not have complications 3 months after mesh insertion, no further follow-up is needed.
e.De novo lower urinary tract symptoms are never a sign of mesh complications.
2.Evaluation of a patient with possible mesh complications includes:
a.history and review of medical records.
b.history and physical examination, conversation with the original surgeon.
c.history and physical examination, review of medical records.
d.history and physical examination, diagnostic imaging, review of medical records.
e.physical examination and diagnostic imaging.
3.Which of the following correctly identifies a possible surgical complication?
a.Levator ani pain after mesh placed vaginally for rectocele repair
b.Sacral pain and osteomyelitis after mesh placed vaginally for cystocele repair
c.Rectal penetration after midurethral sling
d.Rectus muscle pain after mesh placed vaginally for rectocele repair
e.All of the above are correct
4.All of the following are appropriate diagnostic studies for the evaluation of mesh complications, EXCEPT:
a.abdominal radiograph for mesh location.
b.voiding cystourethrogram for urinary obstruction.
c.computed tomographic (CT) scan for abdominal abscess.
d.magnetic resonance imaging (MRI) for osteitis or osteomyelitis.
e.translabial ultrasound for mesh location and size.
5.Mesh products may contain which of the following components?
a.Zero to four arms
b.Tined ends
c.Postinsertion adjustment device
d.Polypropylene material
e.All of the above
6.All of the following are appropriate treatment options for patients with mesh complications, EXCEPT:
a.partial mesh excision.
b.complete mesh excision.
c.medical management of complications.
d.referral to another physician for a second opinion.
e.routine annual follow-up.
7.Patients should be counseled regarding risks of some mesh placement procedures, including:
a.mesh exposure (1% to 19%).
b.buttock, groin, or pelvic pain (0% to 18%) and de novo dyspareunia (2% to 28%).
c.mesh exposure (10%) and reoperation (8%).
d.reoperation (1% to 22%).
e.a, b, and d.
8.Which of the following is correct regarding outcomes of mesh removal?
a.Surgical removal of mesh may improve pain in the majority of patients
b.Risk of anterior prolapse recurrence after mesh removal is 60%.
c.Risk of incontinence after sling removal ranges from 30% to 50%.
d.a and c only
e.a, b, and c
Answers
1.c. Vaginal estrogen sometimes resolves mesh exposure. Answers a, b, and e suggest that complications always present similarly, which is incorrect. Answer d suggests that complications always present within 3 months following insertion, which is also incorrect. Complications may present in a variety of ways, and at any time.
2.d. History and physical examination, diagnostic imaging, review of medical records. History and physical examination are essential components of evaluation. Review of medical records and diagnostic imaging may also be useful in select patients.
3.a. Levator ani pain after mesh placed vaginally for rectocele repair. Levator ani, gluteal pain, and rectal penetration have been described after rectocele repairs performed with mesh augmentation. Sacral pain and osteomyelitis have been described after suspensions of the uterus, cervix, or vagina to the sacrum. Rectus muscle pain is typically described after midurethral sling placement.
4.a. Abdominal radiograph for mesh location. Abdominal radiograph is not commonly utilized for identification of mesh location. Answers b, c, d, and e all describe diagnostic studies that may be useful in select patients.
5.e. All of the above. The term "mesh products" is used to describe a multitude of products. Variation exists in product composition, fixation mechanism, shape, and additional features.
6.e. Routine annual follow-up. Patients with complications should be followed up closely for improvement, and answer e is appropriate for patients without complications.
7.e. a, b, and d. This describes the recommended counseling for patients undergoing mesh placement procedures.
8.d. a and c only. There is a 20% risk of recurrent anterior prolapse after mesh removal.
Chapter review
1.With the use of mesh in the vaginal area, there is a 10% erosion rate and up to a 28% incidence of dyspareunia.
2.Pain complications on occasion cannot be reversed, even with complete removal of the mesh.
3.Mesh exposure and dyspareunia may occur years later as vaginal atrophy occurs with aging.
4.There is a 30% to 50% risk of incontinence following sling excision, and
a 20% incidence of anterior compartment prolapse.